Neurotrophic Mechanisms in Drug Addiction

NeuroMolecular Medicine

Volumn 5, Issue 1, 2004, Pages 69-83

  Bolaños, Carlos A ^a   Nestler, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Brain derived neurotrophic factor (BDNF); Cocaine, morphine; Nucleus accumbens; Trk receptor; Ventral tegmental area

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; COCAINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MORPHINE; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; PSYCHOSTIMULANT AGENT; SOMATOMEDIN C;

ANIMAL CELL; BIOLOGICAL MODEL; BRAIN FUNCTION; CELL DIFFERENTIATION; CELL SURVIVAL; DRUG DEPENDENCE; DRUG MECHANISM; HUMAN; HUMAN CELL; LEARNING; MEMORY; MOOD DISORDER; NERVE CELL; NEUROSCIENCE; NEUROTROPISM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM;

ANIMALIA;

EID: 18144438661     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/nmm:5:1:069     Document Type: Review

References (120)

1. Abrous, D. N., Adriani, W., Montaron, M. F., et al. (2002) Nicotine self-administration impairs hippocampal plasticity. J. Neurosci. 22, 3656-3662.
2. Alonso, M., Vianna, M. R., Depino, A. M., et al. (2002) BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formation. Hippocampus 12, 551-560.
3. Barbacid, M. (1995) Neurotrophic factors and their receptors. Curr. Opin. Cell Biol. 7, 148-155.
4. Barde, Y. (1989) Trophic factors and neuronal survival. Neuron 2, 1525-1534.
5. Barde, Y. A. (1994) Neurotrophins: a family of proteins supporting the survival of neurons. Prog. Clin. Biol. Res. 390, 45-56.
6. Barrot, M., Olivier, J. D., Perrotti, L. I., et al. (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. USA. 99,11435-11440.
7. Batchelor, P. E., Liberatore, G. T., Porritt, M. J., Donnan, G. A., Howells, D. W. (2000) Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum. Eur. J. Neurosci. 12, 3462-3468.
8. Beitner-Johnson, D., and Nestler, E. J. (1991) Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem. 57, 344-347.
9. Beitner-Johnson, D., and Nestler, E. J. (1993a) Chronic morphine impairs axoplasmic transport in the mesolimbic dopamine system of the rat brain. NeuroReport 5, 57-60.
10. Beitner-Johnson, D., and Nestler, E. J. (1993b) Chronic morphine decreases insulin-like growth factor-I levels in the ventral tegmental area of the rat brain. Ann. NY Acad. Sci. 692, 246-248.
11. Beimer-Johnson, D., Guitart, X., Nestler, E. J. (1992) Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12, 2165-2176.
12. Beitner-Johnson, D., Guitart, X., Nestler, E. J. (1993) Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem. 61, 1766-1773.
13. Berhow, M. T., Hiroi, N., Nestler, E. J. (1996a) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707-4715.
14. Berhow, M. T., Hiroi, N., Kobierski, L. A., Hyman, S. E., Nestler, E. J. (1996b) Influence of cocaine on the JAK-STAT pathway in the mesolimbic dopamine system. J. Neurosci. 16, 8019-8026.
15. Berhow, M. T., Russell, D. S., Terwilliger, R. Z., et al. (1995) Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68, 969-979.
16. Berridge, M. J., Lipp, P., Bootman, M. D. (2000) The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21.
17. Berridge, M. J., Bootman, M. D., Roderick, H. L. (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517-529.
18. Bibb, J. A., Chen, J., Taylor, J. R., et al. (2001) Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410, 376-380.
19. Bibel, M., and Barde, Y. A. (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 14, 2919-2937.
20. Bolanos, C. A., Olson, V. G., Eisch, A. J., Russell, D. S., Neve, R. L., Nestler, E. J. (2001) Viral-mediated expression of phospholipase C-gamma 1 and insulin receptor substrate-2 in the ventral tegmental area regulates sensitivity to drugs of abuse in rats. Soc. Neurosci. Abstr. 27.
21. Bolanos, C. A., Perrotti, L. I., Edwards, S., et al. (2003) Phospholipase Cgamma in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors. J. Neurosci. 23, 7569-7576.
22. Bonci, A., Malenka, R. C. (1999) Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J. Neurosci. 19, 3723-3730.
23. Bonni, A., and Greenberg, M. E. (1997) Neurotrophin regulation of gene expression. Can. J. Neurol. Sci. 24, 272-283.
24. Carlezon, W. A., Jr., Boundy, V. A., Haile, C. N., et al. (1997) Sensitization to morphine induced by viral-mediated gene transfer. Science 277, 812-814.
25. Carlezon, W. A., Jr., Thome, J., Olson, V. G., et al. (1998) Regulation of cocaine reward by CREB. Science 282, 2272-2275.
26. Carpenter G. and Ji Q. (1999) Phospholipase C-gamma as a signal-transducing element. Exp. Cell Res. 253, 15-24.
27. Ceccatelli, S., Ernfors, P., Villar, M. J., Persson, H., Hokfelt, T. (1991) Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc. Natl. Acad. Sci. USA. 88, 10352-10356.
28. Chao, M. V. (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309.
29. Conner, J. M., Lauterborn, J. C., Yan, Q., Gall, C. M., Varon, S. (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17, 2295-2313.
30. Danzer, S. C., Crooks, K. R., Lo, D. C., McNamara, J. O. (2002) Increased expression of brain-derived neurotrophic factor induces formation of basal dendrites and axonal branching in dentate granule cells in hippocampal explant cultures. J. Neurosci. 22, 9754-9763.
31. Dechant, G., and Neumann, H. (2002) Neurotrophins. Adv. Exp. Med. Biol. 513, 303-334.
32. Dhavan, R., and Tsai, L. H. (2001) A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749-759.
33. Di Chiara, G. (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375, 13-30.
34. Di Chiara, G., and North, R. A. (1992) Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13, 185-193.
35. Downward, J. (2001) The ins and outs of signalling. Nature 411, 759-762.
36. Duman, R. S. (2002) Synaptic plasticity and mood disorders. Mol. Psychiatry 7(suppl 1) S29-S34.
37. Eisch, A. J., Barrot, M., Schad, C. A., Self, D. W., Nestler, E. J. (2000) Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl. Acad. Sci. USA. 97, 7579-7584.
38. Flores, C., Rodaros, D., Stewart, J. (1998) Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist. J. Neurosci. 18, 9547-9555.
39. Flores, C., Samaha, A. N., Stewart, J. (2000) Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine. J. Neurosci. 20, RC55.
40. Freeman, A. Y., and Pierce, R. C. (2002) Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats. Synapse 46, 57-65.
41. Gash, D. M., Zhang, Z., Ovadia, A., et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-3255.
42. Ghosh, A., and Greenberg, M. E. (1995) Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268, 239-247.
43. Gould, E., Tanapat, P., Hastings, N. B., Shors, T. J. (1999) Neurogenesis in adulthood: a possible role in learning. Trends Cogn. Sci. 3, 186-192.
44. Graybiel, A. M. (2000) The basal ganglia. Curr. Biol. 10, R509-R511.
45. Griffin, J. W., Clark, A. C., Parhad, I., Watson, D. F., Hoffman, P. N. (1991) The neuronal cytoskeleton in disorders of the motor neuron. Adv. Neurol. 56, 103-113.
46. Grimm, J. W., Lu, L., Hayashi, T., Hope, B. T., Su, T. P., Shaham, Y. (2003) Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 23, 742-747.
47. Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J. C., Sokoloff, P. (2001) BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411, 86-389.
48. Hall, F. S., Drgonova, J., Goeb, M., Uhl, G. R. (2003) Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28, 1485-1490.
49. Hoffman, P. N., Griffin, J. W., Price, D. L. (1984) Control of axonal caliber by neurofilament transport. J. Cell. Biol. 99, 705-714.
50. Hoffman, P. N., Cleveland, D. W., Griffin, J. W., Landes, P. W., Cowan, N. J., Price, D. L. (1987) Neurofilament gene expression: a major determinant of axonal caliber. Proc. Natl. Acad. Sci. USA. 84, 3472-3476.
51. Horch, H. W., and Katz, L. C. (2002) BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat. Neurosci. 5, 1177-1184.
52. Horger, B. A., Iyasere, C. A., Berhow, M. T., Messer, C. J., Nestler, E. J., Taylor, J. R. (1999) Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19, 4110-4122.
53. Hyman, C., Juhasz, M., Jackson, C., Wright, P., Ip, N. Y., Lindsay, R. M. (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14, 335-347.
54. Hyman, S. E., and Malenka, R. C. (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695-703.
55. Ip, N. Y., Nye, S. H., Boulton, T. G., et al. (1992) CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69, 1121-1132.
56. Isackson, P. J., Huntsman, M. M., Murray, K. D., Gall, C. M. (1991) BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 6, 937-948.
57. Izzo, E., Martin-Fardon, R., Koob, G. F., Weiss, F., Sanna, P. P. (2002) Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nat. Neurosci. 5, 1263-1264.
58. Kalivas, P. W., Striplin, C. D., Steketee, J. D., Klitenick, M. A., Duffy, P. (1992) Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann. NY Acad. Sci. 654, 128-135.
59. Kaplan, D. R., and Miller, F. D. (2000) Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381-391.
60. Kelley, A. E., and Berridge, K. C. (2002) The neuroscience of natural rewards: relevance to addictive drugs. J. Neurosci. 22, 3306-3311.
61. Kempermann, G., van Praag, H., Gage, F. H. (2000) Activity-dependent regulation of neuronal plasticity and self repair. Prog, Brain Res, 127, 35-48.
62. Kernie, S. G., and Parada, L. F. (2000) The molecular basis for understanding neurotrophins and their relevance to neurologic disease. Arch. Neurol. 57, 654-657.
63. Koob, G. F., and Nestler, E. J. (1997) The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9, 482-497.
64. Koob, G. F., Sanna, P. P., Bloom, F. E. (1998) Neuroscience of addiction. Neuron 21, 467-476.
65. Lee, F. S., Kim, A. H., Khursigara, G., Chao, M. V. (2001) The uniqueness of being a neurotrophin receptor. Curr. Opin. Neurobiol. 11, 281-286.
66. Lindsay, R. M., Weigand, S. J., Altar, C. A., DiStefano, P. S. (1994) Neurotrophic factors: from molecules to man. Trends Neurosci. 17, 182-190.
67. Lu, B., and Figurov, A. (1997) Role of neurotrophins in synapse development and plasticity. Rev. Neurosci. 22, 295-318.
68. McFarlane, S. (2000) Dendritic morphogenesis: building an arbor. Mol. Neurobiol. 22, 1-9.
69. Messer, C. J., Eisch, A. J., Carlezon, W. A., Jr., et al. (2000) Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26, 247-257.
70. Myers, M. G., Jr., Backer, J. M., Sun, X. J., et al. (1992) IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc. Natl. Acad. Sci. USA. 89, 10350-10354.
71. Nestler, E. J. (1992) Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450.
72. Nestler, E. J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128.
73. Nestler, E. J. (2002) Common molecular and cellular substrates of addiction and memory. Neurobiol. Learn. Mem. 78, 637-647.
74. Nestler, E. J., Berhow, M. T., Brodkin, E. S. (1996) Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol. Psychiatry. 1, 190-3199.
75. Nestler, E. J., Bergson, C. M., Gultart, X., Hope, B. T. (1993) Regulation of neural gene expression in opiate and cocaine addiction. NIDA Res. Monogr. 125, 92-116.
76. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., Monteggia, L. M. (2002) Neurobiology of depression. Neuron 34, 13-25.
77. Nixon, K., and Crews, F. T. (2002) Binge ethanol exposure decreases neurogenesis in adult rat hippocampus. J. Neurochem. 83, 1087-1093.
78. Norrholm, S. D., Bibb, J. A., Nestler, E. J., Ouimet, C. C., Taylor, J. R., Greengard, P. (2003) Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 116, 19-22.
79. Numan, S., and Seroogy, K. B. (1999) Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J. Comp. Neurol. 403, 295-308.
80. Ortiz, J., Harris, H. W., Guitart, X., Terwilliger, R. Z., Haycock, J. W., Nestler, E. J. (1995a) Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J. Neurosci. 15, 1285-1297.
81. Ortiz, J., Fitzgerald, L. W., Charlton, M., et al. (1995b) Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 21, 289-298.
82. Patterson, S. L., Abel, T., Deuel, T. A., Martin, K. C., Rose, J. C., Kandel, E. R. (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16, 1137-31145.
83. Phillips, H. S., Hains, J. M., Laramee, G. R., Rosenthal, A., Winslow, J. W. (1990) Widespread expression of BDNF but not NT3 by target areas of basal fore-brain cholinergic neurons. Science 250, 290-3294.
84. Pierce, R. C., and Bari A. A. (2001) The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev. Neurosci. 12, 95-110.
85. Pierce, R. C., Pierce-Bancroft, A. F., Prasad, B. M. (1999) Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. J. Neurosci. 19, 8685-8695.
86. Pilla, M., Perachon, S., Sautel, F., et al. (1999) Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400, 371-375.
87. Poo, M. M. (2001) Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2, 243-#32.
88. Rhee, S. G. (2001) Regulation of Phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70, 281-312.
89. Richtand, N. M., Logue, A. D., Welge, J. A., et al. (2000) The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine. Brain Res. 867, 239-242.
90. Robbins, T. W., and Everitt, B. J. (1996) Neurobehavioural mechanisms of reward and motivation. Curr. Opin. Neurobiol. 6, 228-236.
91. Robinson, T. E., and Kolb, B. (1997) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17, 8491-38497.
92. Robinson, T. E., and Kolb, B. (1999) Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 33, 160-162.
93. Robinson, T. E., Gorny, G., Mitton, E., Kolb, B. (2001) Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39, 257-3266.
94. Robinson, T. E., Gorny, G., Savage, V. R., Kolb, B. (2002) Widespread but regionally specific effects of experimenter-versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 46, 271-3279.
95. Ross, C. A., MacCumber, M. W., Glatt, C. E., Snyder, S. H. (1989) Brain phospholipase C isozymes: differential mRNA localizations by in situ hybridization. Proc. Natl. Acad. Sci. USA. 86, 2923-2927.
96. Russell, D. (1995) Neurotrophins: mechanisms of action. Neuroscientist 1, 3-36.
97. Russo-Neustadt, A. (2003) Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders. Semin. Clin. Neuropsychiatry 8, 109-3118.
98. Schuman, E. M. (1999) Neurotrophin regulation of synaptic transmission. Curr. Opin. Neurobiol. 9, 105-109.
99. Segal, R. A., and Greenberg, M. E. (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463-489.
100. Self, D. W., and Nestler, E. J. (1995) Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18, 463-495.
101. Self, D. W., McClenahan, A. W., Beitner-Johnson, D., Terwilliger, R. Z., Nestler, E. J. (1995) Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21, 312-318.
102. Self, D. W., Genova, L. M., Hope, B. T., Barnhart, W. J., Spencer, J. J., Nestler, E. J. (1998) Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18, 1848-1859.
103. Seroogy, K. B., and Gall, C. M. (1993) Expression of neurotrophins by midbrain dopaminergic neurons. Exp. Neurol. 124, 119-128.
104. Seroogy, K. B., Lundgren, K. H., Tran, T. M., Guthrie, K. M., Isackson, P. J., Gall, C. M. (1994) Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342, 321-334.
105. Sklair-Tavron, L., Shi, W. X., Lane, S. B., Harris, H. W., Bunney, B. S., Nestler, E. J. (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. USA. 93, 11202-11207.
106. Sorg, B. A., Chen, S. Y., Kalivas, P. W. (1993) Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 266, 424-430.
107. Spenger, C., Hyman, C., Studer, L., et al. (1995) Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon. Exp. Neurol. 133, 50-63.
108. Sun, X. J., Wang, L. M., Zhang, Y., et al. (1995) Role of IRS-2 in insulin and cytokine signalling. Nature 377, 173-177.
109. Terwilliger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M., Nestler, E. J. (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548, 100-110.
110. Tomac, A., Lindqvist, E., Lin, L. F., et al. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
111. Tyler, W. J., Perrett, S. P., Pozzo-Miller, L. D. (2002) The role of neurotrophins in neurotransmitter release. Neuroscientist 8, 524-531.
112. Valjent, E., Corvol, J. C., Pages, C., Besson, M. J., Maldonado, R., Caboche, J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701-8709.
113. Vorel, S. R., Ashby, C. R., Jr., Paul, M., et al. (2002) Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 22, 9595-9603.
114. Wallace, D. R., Mactutus, C. F., Booze, R. M. (1996) Repeated intravenous cocaine administration: locomotor activity and dopamine D2/D3 receptors. Synapse 23, 152-163.
115. Wise, R. A. (1996) Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243-251.
116. Wolf, D. H., Numan, S., Nestler, E. J., Russell, D. S. (1999) Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration. J Neurochemistry 73, 1520-1528.
117. Wolf, M. E. (2002) Addiction: making the connection between behavioral changes and neuronal plasticity in specific pathways. Mol. Intervent. 2, 146-157.
118. Wolf, M. E. (2003) LTP may trigger addiction. Mol. Intervent. 3, 248-252.
119. Wujek, J. R., Lasek, R. J., Gambetti, P. (1986) The amount of slow axonal transport is proportional to the radial dimensions of the axon. J. Neurocytol. 15, 75-83.
120. Yamada, K., and Nabeshima, T. (2003) Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 91, 267-270.